Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2012
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
The Lancet. Oncology
|
December 17, 2017
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial
Jeffrey A Jones, Anthony R Mato, William G Wierda, et al.
Frontiers in Immunology
|
March 17, 2022
Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-<i>Versus</i>-Host Disease While Preserving Graft-Versus-Leukemia Effect
Ying Huang, Yujing Zou, Yiqun Jiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
Max J Gordon, Andy Kaempf, Andrea Sitlinger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2014
Derivation of naive human embryonic stem cells
Carol B Ware, Angelique M Nelson, Brigham Mecham, et al.
Cancer Research
|
June 30, 2011
HIF induces human embryonic stem cell markers in cancer cells
Julie Mathieu, Zhan Zhang, Wenyu Zhou, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue
Nadine Goldhammer, Marin Bont, Shruti Warhadpande, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 19, 2008
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model
Kai Fu, Michael J Corbley, Lihong Sun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 14, 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M Horwitz, Stephen M Ansell, Weiyun Z Ai, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2012
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
The Lancet. Oncology
|
December 17, 2017
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial
Jeffrey A Jones, Anthony R Mato, William G Wierda, et al.
Frontiers in Immunology
|
March 17, 2022
Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-<i>Versus</i>-Host Disease While Preserving Graft-Versus-Leukemia Effect
Ying Huang, Yujing Zou, Yiqun Jiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
Max J Gordon, Andy Kaempf, Andrea Sitlinger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2014
Derivation of naive human embryonic stem cells
Carol B Ware, Angelique M Nelson, Brigham Mecham, et al.
Cancer Research
|
June 30, 2011
HIF induces human embryonic stem cell markers in cancer cells
Julie Mathieu, Zhan Zhang, Wenyu Zhou, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue
Nadine Goldhammer, Marin Bont, Shruti Warhadpande, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 19, 2008
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model
Kai Fu, Michael J Corbley, Lihong Sun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 14, 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M Horwitz, Stephen M Ansell, Weiyun Z Ai, et al.
Page
of 8